Evaluating Effects of Glatiramer Acetate Treatment on Amyloid Deposition and Tau Phosphorylation in the 3xTg Mouse Model of Alzheimer’s Disease. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.